After UK approval there got to be a major change in NWBO mgt structure. LP needs to strengthen the management as well bringing other scientific personnel like Dr. P Kalinski. The reason is we need to start initiate trials for other type of cancers like Pancreas cancer with 500K globally as well as Sarcomas cancer with 100K. These type of cancers are deadly with OS less than 1 yr in case of P cancer. There are many works in front of their mgt. Unless there is a discussion of BO after approval.
Market Data 
Markets 
AI
